Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer

Purpose: Radiotherapy is a promising treatment option for lung cancer, but patients’ responses vary. The purpose of the study was to investigate the potential of radiomics and clinical signature for predicting the radiotherapy sensitivity and overall survival of inoperable stage III and IV non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenrui, Wang, Li, Hou, Yu, Li, Lan, Chang, Li, Li, Yunfen, Xie, Kun, Qiu, Linbo, Mao, Dan, Li, Wenhui, Xia, Yaoxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Screening, diagnosis, and treatment of lung cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742722/
https://www.ncbi.nlm.nih.gov/pubmed/36476110
http://dx.doi.org/10.1177/15330338221142400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742722/
https://www.ncbi.nlm.nih.gov/pubmed/36476110
http://dx.doi.org/10.1177/15330338221142400

Ejemplares similares